Tangningtongluo Tablet in the Treatment of Non-proliferative Diabetic Retinopathy
Status:
Recruiting
Trial end date:
2023-03-29
Target enrollment:
Participant gender:
Summary
This trial is planned to collect relevant clinical data to evaluate the prevention efficacy
and safety of Tangningtongluo tablets on the non-proliferation period of diabetic
retinopathy.